最終更新日：2025/11/25
(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze.
音声機能が動作しない場合はこちらをご確認ください
正解を見る
saxagliptin
編集履歴（0）
元となった辞書の項目
saxagliptin
IPA（発音記号）
名詞
不可算名詞
(pharmacology)
A
hypoglycemic
drug
taken
orally
in
the
form
of
its
hydrate
C₁₈H₂₅N₃O₂·H₂O
in
the
treatment
of
type
2
diabetes.
It
acts
by
inhibiting
the
degradation
of
incretins,
which
results
in
increased
secretion
of
insulin
by
the
pancreas.
It
is
marketed
under
the
trademark
Onglyza
and
when
used
in
combination
with
metformin,
under
the
trademark
Kombiglyze.
日本語の意味
サクサグリプチン：経口投与される低血糖薬で、主に2型糖尿病の治療に用いられます。インクレチンの分解を阻害することによって膵臓からのインスリン分泌を促進する作用があり、商標名「Onglyza」で販売され、またメトホルミンとの併用時は「Kombiglyze」としても知られています。
意味（1）
(pharmacology)
A
hypoglycemic
drug
taken
orally
in
the
form
of
its
hydrate
C₁₈H₂₅N₃O₂·H₂O
in
the
treatment
of
type
2
diabetes.
It
acts
by
inhibiting
the
degradation
of
incretins,
which
results
in
increased
secretion
of
insulin
by
the
pancreas.
It
is
marketed
under
the
trademark
Onglyza
and
when
used
in
combination
with
metformin,
under
the
trademark
Kombiglyze.
